Diabetes Technology & Therapeutics · 2010 · 28 citations · 14 references
MedicineEndocrinologyAgingDiabetologyHuman NutritionAging PhysiologyDiabetes ManagementDiabetes MellitusGlucose HomeostasisGlycemic ControlGlycemic MonitoringAdvanced Glycation End ProductsAutofluorescenceAutofluorescence ImagingGlycemic BiomarkersHemoglobin A1c TestingImpaired Glucose TolerancePostprandial GlycemiaPostprandial Glycemic Response
BACKGROUND: Accumulation of advanced glycation end products (AGEs) is accelerated during glycemic and oxidative stress and is an important predictor of complications in diabetes mellitus (DM). STUDY DESIGN: Here we both review and present original data on the relationship between skin autofluorescence (SAF), a noninvasive measure of AGEs, and short- and intermediate-term glycemic variations. RESULTS: Acute changes in glucose levels during an oral glucose tolerance test in 56 persons with varying degrees of glucose tolerance did not influence SAF. AGE-rich meals result in a transient postprandial rise in SAF of 10% 2-4 h later. This could not be attributed to meal-induced glycemic changes and is probably caused by the AGE content of the meal. In type 1 DM major intermediate-term improvements of glycemic control as depicted by multiple hemoglobin A1c (HbA1c) measurements were associated with lower skin AGE levels. In a well-controlled, stable type 2 DM cohort, only a weak correlation was found between SAF and HbA1c. In both studies skin AGE/SAF levels predicted complications of diabetes with an accuracy superior to that of HbA1c. SAF has also been proposed as a new tool in diagnosing impaired glucose tolerance (IGT) and DM. It proved to be more sensitive than either fasting glucose or HbA1c. CONCLUSIONS: SAF is not influenced by short-term glycemic variations. AGE-rich meals may, however, cause a transient rise postprandially. There is a weak correlation between SAF or skin AGEs and current or time-integrated HbA1c levels. SAF has strong added value in risk prediction of complications of diabetes and is a promising tool for early detection of diabetes and IGT.
14
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel et al. · New England Journal of Medicine · 2008 · 7.8K citations · Full text
Simple non-invasive assessment of advanced glycation endproduct accumulation
Robbert Meerwaldt, R. Graaff, P. H. N. Oomen et al. · Diabetologia · 2004 · 759 citations · Full text
Vincent M. Monnier, O. Bautista, Danelle Kenny et al. · Diabetes · 1999 · 463 citations · Full text
Saul Genuth, Wanjie Sun, Patricia A. Cleary et al. · Diabetes · 2005 · 423 citations · Full text